- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | hCG Assay Sample Diluent, Pregnancy Test Validated |
| Catalog No. | ATRD-0011 |
| Description | A specially formulated diluent for the quantitative determination of human chorionic gonadotropin in serum and urine specimens, eliminating high-dose hook effect and enabling accurate measurements across the clinical range. |
| Intended Use | Diluting serum and urine specimens for quantitative hCG measurement in pregnancy testing, gestational trophoblastic disease monitoring, and oncology applications. |
| Principle / Technology | Buffered protein matrix containing non-human proteins that eliminate heterophilic antibody interference while providing linear dilution recovery across 0–10,000 mIU/mL. |
| Detection Method | hCG recovery by CLSI EP06 linearity protocol, hook effect verification |
| Sample Type | Human serum, EDTA plasma, urine |
| Performance Range / Specifications | hCG recovery 90–110% across 1:2 to 1:1000 dilutions; hook effect eliminated at levels up to 500,000 mIU/mL |
| Sensitivity / LOD | N/A |
| Specificity | No cross-reactivity with LH, FSH, or TSH at physiological levels |
| Reaction Conditions / Protocol | Use undiluted; dilute samples that exceed assay upper limit; accuracy of dilution factor verified by linearity protocol. |
| Components / Formulation | Tris-buffered saline pH 7.4, non-human protein matrix, non-ionic surfactant, ProClin 300 |
| Storage Conditions | 2–8°C |
| Shelf Life | 18 months |
| Package Specifications | 50 mL, 100 mL |
| Product Form | Liquid, ready to use |
| Quality Control | hCG linearity verification, heterophilic antibody interference testing, lot-to-lot recovery |
| Key Features | Hook effect resistant formulation; validated for pregnancy and oncology hCG assays; low cross-reactivity with pituitary hormones |
For research use only, not for clinical use.
|
There is no product in your cart. |